Search results for "Chlorthalidone"

showing 4 items of 4 documents

Contemporary Management of Struvite Stones Using Combined Endourologic and Medical Treatment: Predictors of Unfavorable Clinical Outcome

2016

Struvite stones have been associated with significant morbidity and mortality, yet there has not been a report on the medical management of struvite stones in almost 20 years. We report on the contemporary outcomes of the surgical and medical management of struvite stones in a contemporary series.A retrospective review of patients who were treated with percutaneous nephrolithotomy (PCNL) for struvite stones at Duke University Medical Center between January 2005 and September 2012 identified a total of 75 patients. Of these, 43 patients had adequate follow-up and were included in this analysis. Stone activity, defined as either stone recurrence or stone-related events, and predictors of acti…

AdultMalemedicine.medical_specialtyStruviteUrologymedicine.medical_treatment030232 urology & nephrologyComorbidityHydroxamic AcidsKidney CalculiYoung Adult03 medical and health scienceschemistry.chemical_compoundPostoperative Complications0302 clinical medicineRecurrencePotassium CitratemedicineHumansUniversity medicalEnzyme InhibitorsDiureticsPercutaneous nephrolithotomyAgedNephrostomy PercutaneousRetrospective StudiesAged 80 and overRetrospective reviewMedical treatmentbusiness.industryChlorthalidoneRetrospective cohort studyMiddle Agedmedicine.diseaseComorbidityAnti-Bacterial AgentsSurgerySodium BicarbonateTreatment OutcomechemistryStruvite030220 oncology & carcinogenesisNephrostomyFemaleCalcium CitratebusinessJournal of Endourology
researchProduct

Chromatographic separation of chlorthalidone enantiomers using β-cyclodextrins as chiral additives

2000

Different beta-cyclodextrins have been tested as chiral additives in the mobile phase for the chromatographic analysis of chlorthalidone enantiomers in a C18 LiChrospher (125 x 4 mm I.D.) column. The effect on enantioresolution of different parameters was studied: composition of the mobile phase (percentage of organic solvent, type of buffer and pH), mobile phase flow-rate, and type and concentration of beta-cyclodextrin. A 25:75 mixture of methanol and 0.1 M phosphate buffer, pH 4, containing 2% triethylamine (v/v), and 12.5 mM beta-cyclodextrin, at a flow-rate of 0.8 ml/min, was found to be the best option for the resolution of chlorthalidone enantiomers. Under such conditions, linear cal…

Beta-Cyclodextrinschemistry.chemical_compoundSpectrophotometrymedicineHumansDiureticsTriethylaminechemistry.chemical_classificationDetection limitCyclodextrinsChromatographyCyclodextrinmedicine.diagnostic_testbeta-CyclodextrinsChlorthalidoneStereoisomerismGeneral ChemistrySolutionschemistrySolventsIndicators and ReagentsSpectrophotometry UltravioletChlorthalidoneMethanolEnantiomermedicine.drugJournal of Chromatography B: Biomedical Sciences and Applications
researchProduct

Simple and sensitive reversed-phase liquid chromatographic assay for analysis of chlorthalidone in urine

1993

Abstract This study describes a rapid method for the determination of chlorthalidone in human urine by reversed-phase liquid chromatography and UV detection at 230 nm, after clean-up over a C8 solid-phase extraction column. Liquid chromatography was carried out on a C18-bonded phase using acetonitrile-phosphate buffer (pH=3) gradient elution. Triamterene was used as internal standard. The system has been applied to the determination of chlorthalidone in the 0.10–10.0 μg/mL concentration interval; the limit of detection was 6 ng/mL.

Detection limitTriamtereneChromatographyChemistryExtraction (chemistry)medicineMolecular MedicineChlorthalidoneSolid phase extractionReversed-phase chromatographyHigh-performance liquid chromatographyQuantitative analysis (chemistry)medicine.drug
researchProduct

Diuretic Strategies in Acute Heart Failure and Renal Dysfunction: Conventional vs Carbohydrate Antigen 125-guided Strategy. Clinical Trial Design

2017

Abstract Introduction and objectives The optimal treatment of patients with acute heart failure (AHF) and cardiorenal syndrome type 1 (CRS-1) is far from being well-defined. Arterial hypoperfusion in concert with venous congestion plays a crucial role in the pathophysiology of CRS-I. Plasma carbohydrate antigen 125 (CA125) has emerged as a surrogate of fluid overload in AHF. The aim of this study was to evaluate the clinical usefulness of CA125 for tailoring the intensity of diuretic therapy in patients with CRS-1. Methods Multicenter, open-label, parallel clinical trial, in which patients with AHF and serum creatinine ≥ 1.4 mg/dL on admission will be randomized to: a) standard diuretic str…

medicine.medical_specialtymedicine.medical_treatmentWater-Electrolyte ImbalanceRenal functionCardiorenal syndrome030204 cardiovascular system & hematologyPatient Care Planning03 medical and health scienceschemistry.chemical_compound0302 clinical medicineFurosemideInternal medicineHumansMedicine030212 general & internal medicineDiureticsIntensive care medicineHeart FailureCreatinineCardio-Renal Syndromebusiness.industryClinical study designChlorthalidoneMembrane ProteinsGeneral Medicinemedicine.diseasePathophysiologyAcetazolamideClinical trialchemistryCA-125 AntigenCreatinineHeart failureAcute DiseaseCardiologyDiureticbusinessRevista Española de Cardiología (English Edition)
researchProduct